Study question: The aim of the study was to investigate specific effects of an overproduction of androgens on brain activity during working memory processes in women with a Polycystic Ovarian Syndrome (PCOS) Summary answer: Our main conclusion is that women with PCOS need additional resources during a working-memory task, suggesting less efficient executive functioning with regard to working-memory compared to women without PCOS What is known already: Working-memory is a specific cognitive component of temporal storage and manipulation of information and is needed for multiple processes of cognition, such as language, perceptual speed, but also verbal and visual memory and planning. Possible deficits may affect daily functioning and behaviour. This is the first MRI study with a focus to working-memory in women with PCOS and hyper androgenism. Study design, size, duration: In this study we used a cross-sectional design between women with PCOS with hyper androgenism compared to women without PCOS (controls). In total, we investigated 34 participants (fourteen women with PCOS and twenty controls with the use of functional MRI, a neuropsychological assessment and blood samples were withdrawn. Participants/materials, setting, methods: Fourteen women with PCOS combined with hyper androgenism and 20 controls underwent functional MRI scanning while performing a working memory task (N-Back). During this task participants monitored a series of letters and were asked to indicate whether this letter was also presented n (n ¼ 1, 2 or 3) steps previously. Main results and the role of chance: Analysis of the blood samples showed higher levels of androgens in the PCOS group (p ¼ 0.009). The task performance did not differ between the two groups for mean reaction time nor accuracy of the answers.However, brain activation patterns did differ significantly between the two groups. The group with PCOS showed more activation within the superior parietal lobe right and the inferior parietal lobe left during all given N-Back stimuli. This finding may suggest that women with PCOS need additional resources during a working-memory task, suggesting less efficient executive functioning compared to women without PCOS. Limitations, reason for caution: Because we only wanted to include homogeneous groups of participants to reduce the risk of possible confounds, recruitment of which proved to be burdensome. Wider implications of the findings: This is the first study investigating the specific effects of PCOS to brain activity. These results suggest less efficient executive functioning in women with PCOS. Although the changes are rather subtle it should be investigated more in depth to investigate if the efficiency of brain activity is less in more cognitive domains. Inefficiency in brain activity of working memory combined with other cognitive deficits may affect daily life functioning in women with PCOS more. For SCSA assay: Meta-analyses of 14 studies (n ¼ 1621) showed a significantly higher clinical pregnancy rate (CPR) in the group who had a DNA fragmentation index (DFI) score of ,30% (Relative risk (RR) 1.17, 95% CI 1.05-1.30; P ¼ 0.004) compared to the group who had a DFI .30%.
For TUNEL assay: Meta-analyses of 8 studies (n ¼ 1233) showed a significantly higher CPR in the group who had a low DNA fragmentation compared to the group who had a high DNA fragmentation (RR 0.69, 95%CI 0.52-0.90, P¼ 0.006).
For Comet assay: Meta-analyses of 3 studies (n¼ 506) showed a significantly higher CPR in the group who had a low DNA fragmentation compared to the group with high DNA fragmentation (RR 1.16, 95%CI, 1.03-1.30, P ¼ 0.01). Limitations, reason for caution: There has been several assays described in the literature to define low and high DNA fragmentation. The diagnostic accuracy of these assays has been widely debated. There is inconsistency in defining the threshold for high DNA fragmentation test. The studies included were heterogeneous and not adequately powered. Wider implications of the findings: Increased sperm DNA fragmentation may have a detrimental effect on IVF outcome. Adequately powered studies with strict inclusion criteria to further evaluate the effect of DNA fragmentation testing in IVF and the role of antioxidants as well as IMSI (intracytoplasmic morphologically selected sperm injected) as treatment options are needed. Study question: Can we diagnose intratubular germ cell neoplasia (IGCN) using the immunohistochemical markers placental-like alkaline phosphatase (PLAP) and OCT3/4 on AgarCytos, made of the remnants of the testicular sperm extraction (TESE) specimen, and what is the incidence of such (pre)malignancies in men with non-obstructive azoospermia (NOA) undergoing TESE for fertility treatment? Summary answer: For the first time, IGCN can be successfully detected by immunohistochemical evaluation of AgarCytos, made of the remnants of TESE biopsies. The observed incidence of a germ cell (pre)malignancy in this specific population was 4.4%. What is known already: Infertile men are at higher risk for testicular cancer compared to the general population. IGCN can be detected by immunohistochemistry in standard testicular biopsies and, albeit less accurate, in semen using PLAP and OCT3/4. Study design, size, duration: Between January 2011 and April 2012 a prospective cohort study was conducted at a Dutch tertiary care academic training hospital. All males with NOA (n ¼ 182) undergoing a urological work-up followed by a diagnostic TESE (n ¼ 251) for fertility treatment were included. Participants/materials, setting, methods: After cryopreservation of sperm, if present, an AgarCyto was made of the remnants of these TESE biopsies. Sections were stained with haematoxylin-eosin for pathological examination as well as PLAP and OCT3/4 for immunohistochemistry to detect IGCN. Main results and the role of chance: Eight men (4.4%) were diagnosed with a germ cell (pre)malignancy: six with seminoma, of which two without and four with concomitant IGCN, and two with IGCN only. Microscopic evaluation including immunohistochemical analysis of the AgarCytos diagnosed three (1.6%) more cases of a germ cell (pre)malignancy compared to scrotal ultrasound alone (one case of bilateral seminoma with concomitant IGCN and two cases of IGCN alone). No falsepositive cytology results were found upon conventional histological evaluation. Limitations, reason for caution: The main limitation of this study is lack of a simultaneously taken standard testicular biopsy, for comparison with our novel diagnostic method. Nevertheless, in all but one of our cases orchidectomy followed and the diagnosis was confirmed by histology, in the remaining case repeat TESE showed similar results. Wider implications of the findings: Men undergoing TESE because of NOA should be offered simultaneous screening for IGCN because of the increased incidence of germ cell (pre)malignancies in this specific population. The principal advantage of our new method is that all available testicular tissue can be used for both sperm recovery and pathological evaluation, increasing the yield of spermatozoa as well as the chance to find (pre)malignant cells. Study funding/competing interest(s): This study was (partially) funded by Merck Serono (Schiphol-Rijk, the Netherlands), but there are no conflicting interests to disclose. Study question: Is there a relationship between the etiopathogenic factors of DNA damage and the presence of large nuclear vacuoles (vacuoles occupy .50% of the nuclear area) in sperm? Summary answer: Our results support the idea that the presence of large nuclear vacuoles in sperm could reflect molecular anomalies, such as abnormal chromatin packaging (underprotamination), mitochondrial damage and apoptosis. What is known already: There is strong clinical evidence supporting an association between increased DNA damage in sperm and abnormalities in several characteristics of semen. Several studies have linked the presence of large nuclear vacuoles (LNV) and increased DNA damage in sperm based on high magnification analyses. Different mechanisms may explain the presence of damaged DNA in human spermatozoa, including abnormal chromatin packaging (underprotamination), mitochondrial damage and apoptosis. Study design, size, duration: A cross-sectional study of semen samples obtained from 608 men who underwent infertility evaluations was conducted from August 2010 to August 2012. Percentages were treated as continuous variables. Correlation analyses were performed using Spearman's rank test. Participants/materials, setting, methods: At least 200 spermatozoa per evaluation were examined from each semen sample. The percentages for the following groups were determined: -Normal and LNV spermatozoa by motile sperm organelle morphology examination(MSOME/15,000x magnification); -Spermatozoa with abnormal chromatin packaging (chromomycin A3); -Spermatozoa with mitochondrial damage (MitoTracker Green); -Spermatozoa in apoptosis (positive for annexin-V). Main results and the role of chance: Regression analysis revealed that abnormal chromatin packaging, mitochondrial damage and apoptosis were positively correlated with the percentage of LNV spermatozoa. Conversely, regression analysis revealed that abnormal chromatin packaging and mitochondrial damage were negatively correlated with the percentage of normal sperm. A significant relationship with apoptosis was not observed (Table 1) . Limitations, reason for caution: This descriptive study was based on in vitro evaluations. Cross-sectional analyses do not allow inferences regarding directionality between observed associations. Therefore, determining the cause and effect between variables is not possible. Wider implications of the findings: Based on the clinical and laboratory findings regarding the repercussions of possible DNA damage in offspring, these data indicate that the use of spermatozoa with LNV should be avoided to obtain embryos with higher implantation and development potential. Study funding/competing interest(s): The authors declare that they have no competing interests. Trial registration number: Not applicable. The local ethics committee authorised this study.
O-024 Punalpin
w increases the numbers of motile sperm in men with reduced semen quality: a prospective, randomized, controlled, doubleblinded trial What is known already: Juice from pomegranate fruit has been shown to stimulate spermatogenesis and to increase sperm motility in rats after seven weeks of gavage (Türk et al. 2008) , and increased sperm counts and motility have been shown in mice, which were given galangal extract for 90 days (Qureshi et al. 1992) . Within traditional medicine, pomegranate fruit has long been used to increase fertility, however studies on the effect on spermatogenesis in humans have never been published. Study design, size, duration: The study was designed as a prospective, randomized, controlled, double-blinded trial. Seventy men with base-line total motile sperm less than 40 million were randomized to take tablets corresponding to approximately 3.5 g fresh galangal rhizome and 1500 ml pomegranate fruit juice or placebo daily for three months. Participants/materials, setting, methods: Participants were recruited from advertisement in Nordic Cryobank and local newspapers. Enrollment was based on mean total number of motile spermatozoa of two ejaculates (with 4-10 days of abstinence). The participants delivered an ejaculate after 4-8 days of tablet-intake and two ejaculates just before they stopped taking the tablets. Main results and the role of chance: From baseline to after three months of Punalpinw intake corresponding to a daily dose of 11 mg ellagic acid, 100 mg punicalagin A, 265 mg punicalagin B (from pomegranate) and 16 mg 1'-acetoxychavicol acetate (from galangal) the average total number of motile sperm increased with 62% (from 23.4 millions to 37.8 millions), while for the placebo group the number of motile sperm increased with 20% (from 19.9 millions to 23.9 millions). This difference in increase between the study and placebo groups was statistically significant (p ¼ 0.026). There was no increase in number of motile sperm after one week of tablet consumption for either of the groups, indicating that the pomegranate and galangal preparations exert their positive effect during spermatogenesis rather than on epididymal sperm. Limitations, reason for caution: It cannot be expected that every participant take 100% of the tablets for the three-months period. The counting of the remaining tablets of all bottles showed that more than 85% of the participants had taken more that 80% of the tablets. Wider implications of the findings: Our findings may help subfertile men to gain an improved amount of motile ejaculated sperm by taking tablets containing preparations of pomegranate fruit skin and rhizome of greater galangal. Consequently, these men may become able to impregnate their partner by natural conception rather than exclusively by ART, or implied fertility treatments may be less invasive. Ultimately, the load on fertility clinics may be reduced. The top-quality embryo rate on day 3 and the blastocyst formation rate on day 5 by IMSI were significantly higher than those by ICSI. However, there is no difference of the implantation rate and the delivery rate between the two groups. What is known already: Morphological selection of fertilizing spermatozoa under a high magnification has been introduced to provide a better clinical outcome than the conventional ICSI. However, it is still a controversial issue whether human sperm head vacuoles affect ICSI outcome or not. Most of the earlier studies showed no effectiveness of IMSI. Study question: The aim of this study is to evaluate if a real-time ultramorphology test of motile spermatozoa so-called MSOME and/or standard sperm morphology assessment could predict IntraCytoplasmic Sperm Injection (ICSI) outcome in terms of fertilization, embryo quality and clinical pregnancy rates. Summary answer: MSOME and standard sperm morphology cannot predict clinical and biological ICSI outcomes. What is known already: Some laboratories routinely use MSOME results to indicate ICSI or IMSI (IntraCytoplasmic Morphologically selected Sperm Injection). Many classifications of MSOME essentially based on sperm head examination under high magnification tries to determine a threshold of sperm head normalcy rate. An obtained rate under the threshold would recommend the use of IMSI. However, most of these thresholds are arbitrarily determined and not evaluated. Study design, size, duration: This is a prospective observational bicentric study setting in two public assisted reproductive technologies (ART) units in France between January and July 2012. A total of 111 ICSI cycles for exclusive male infertility factors were included. Participants/materials, setting, methods: A Spearman correlation test was performed to validate MSOME reproducibility between ART units. Normal morphology rate and MSOME done on selected spermatozoa were respectively determined according to David's and Vanderzwalmen's classifications the day of ICSI. ROC curves analysis was performed to determine thresholds associated with the occurrence of a pregnancy. Main results and the role of chance: We observed an excellent correlation between the two operators (r ¼ 0.98) validating MSOME data of the study. Percentages of normal morphology grade spermatozoa using standard classification and first-best morphology grade spermatozoa determined by MSOME were not significantly associated with (i) clinical pregnancy ( p ¼ 0.58; 0.90 / Area under curve (AUC) ¼0.532; 0.507), (ii) fertilization ( p ¼ 0.88; 0.90), (iii) top quality embryo ( p ¼ 0.27; 0.98) and (iv) good quality embryo rates ( p ¼ 0.73; 0.98), respectively. Limitations, reason for caution: This study is limited by its statistical power which is not very high due to the sample size (111 ICSI cycles, 41 clinical pregnancies).
